Literature DB >> 11844995

Pathophysiology of thalassemia.

Stanley L Schrier1.   

Abstract

Despite discoveries concerning the molecular abnormalities that led to the thalassemic syndromes, it still is not known how accumulation of excess unmatched alpha-globin in beta thalassemia and beta-globin in alpha thalassemia leads to red blood cell hemolysis in the peripheral blood, and in the beta thalassemias particularly, premature destruction of erythroid precursors in marrow (ineffective erythropoiesis). Oxidant injury may cause hemolysis, but there is no evidence that it causes ineffective erythropoiesis. Hemoglobin E/beta thalassemia is now a worldwide clinical problem. The reasons underlying the heterogeneity and occasional severity of the syndrome remain obscure. Ineffective erythropoiesis now appears to be caused by accelerated apoptosis, in turn caused primarily by deposition of alpha-globin chains in erythroid precursors. However, it is not clear how alpha-globin deposition causes apoptosis. The author uses new observations on the control of erythropoiesis to provide a framework for studying the enhanced thalassemic erythroid apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844995     DOI: 10.1097/00062752-200203000-00007

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  45 in total

Review 1.  Chaperoning erythropoiesis.

Authors:  Mitchell J Weiss; Camila O dos Santos
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

2.  An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

Authors:  Michael Dussiot; Thiago T Maciel; Aurélie Fricot; Céline Chartier; Olivier Negre; Joel Veiga; Damien Grapton; Etienne Paubelle; Emmanuel Payen; Yves Beuzard; Philippe Leboulch; Jean-Antoine Ribeil; Jean-Benoit Arlet; Francine Coté; Geneviève Courtois; Yelena Z Ginzburg; Thomas O Daniel; Rajesh Chopra; Victoria Sung; Olivier Hermine; Ivan C Moura
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

3.  A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease.

Authors:  Pathrapol Lithanatudom; Amporn Leecharoenkiat; Tirawat Wannatung; Saovaros Svasti; Suthat Fucharoen; Duncan R Smith
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

4.  Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Authors:  Ilaria V Libani; Ella C Guy; Luca Melchiori; Raffaella Schiro; Pedro Ramos; Laura Breda; Thomas Scholzen; Amy Chadburn; YiFang Liu; Margrit Kernbach; Bettina Baron-Lühr; Matteo Porotto; Maria de Sousa; Eliezer A Rachmilewitz; John D Hood; M Domenica Cappellini; Patricia J Giardina; Robert W Grady; Johannes Gerdes; Stefano Rivella
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

5.  Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.

Authors:  Daniel Garcia-Santos; Amel Hamdi; Zuzana Saxova; Carine Fillebeen; Kostas Pantopoulos; Monika Horvathova; Prem Ponka
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

Review 6.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

7.  Iron Loading and Overloading due to Ineffective Erythropoiesis.

Authors:  Toshihiko Tanno; Jeffery L Miller
Journal:  Adv Hematol       Date:  2010-05-11

8.  beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload.

Authors:  Luca Melchiori; Sara Gardenghi; Stefano Rivella
Journal:  Adv Hematol       Date:  2010-05-19

9.  Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population.

Authors:  Marco Marziali; Antonella Isgrò; Javid Gaziev; Guido Lucarelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-26       Impact factor: 2.576

10.  Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.

Authors:  Abigail A Lamikanra; Michel Theron; Taco W A Kooij; David J Roberts
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.